空腹血糖与髋部骨面积及骨密度的孟德尔随机化研究
该研究采用孟德尔随机化方法,在无糖尿病人群中评估空腹血糖对全髋骨面积和骨密度的影响。遗传预测的空腹血糖每升高1 mmol/l与全髋骨面积减小2%相关,与骨密度升高4%的关联未达统计学显著性。结论提示空腹血糖可能是髋部骨面积减小的因果风险因素,但可能对骨密度有正向影响。
要点
- 遗传预测的空腹血糖每升高1 mmol/l,全髋骨面积减小2%。
- 空腹血糖与全髋骨密度升高4%的关联未达统计学显著性。
- 空腹血糖可能是髋部骨面积减小的因果风险因素。
核心结论
- 空腹血糖可能是髋部骨面积减小的因果风险因素。
- 空腹血糖可能对全髋骨密度有正向影响,但未达统计学显著性。
研究设计与样本
- 采用孟德尔随机化方法,利用35个与空腹血糖强相关的SNP作为工具变量。
- SNP来自MAGIC研究中无糖尿病的欧洲人群(n=133,010)。
- 结局分析纳入瑞典三个队列中无糖尿病的男性和女性共4966人。
主要发现
- 遗传预测的空腹血糖每升高1 mmol/l与全髋骨面积减小2%相关(-0.67 cm2,95% CI -1.30至-0.03,p=0.039)。
- 遗传预测的空腹血糖每升高1 mmol/l与全髋骨密度升高4%相关,但未达统计学显著性(0.040 g/cm2,95% CI -0.00至0.07,p=0.060)。
局限性
- 需要更大样本量的孟德尔随机化研究来证实这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Observational studies indicate that type 2 diabetes mellitus and fasting glucose levels are associated with a greater risk for hip fracture, smaller bone area and higher bone mineral density (BMD). However, these findings may be biased by residual confounding and reverse causation. Mendelian randomisation (MR) utilises genetic variants as instruments for exposures in an attempt to address these biases. Thus, we implemented MR to determine whether fasting glucose levels in individuals without diabetes are causally associated with bone area and BMD at the total hip. METHODS: We selected 35 SNPs strongly associated with fasting glucose (p < 5 × 10-8) in a non-diabetic European-descent population from the Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) (n = 133,010). MR was used to assess the associations of genetically predicted fasting glucose concentrations with total hip bone area and BMD in 4966 men and women without diabetes from the Swedish Mammography Cohort, Prospective Investigation of Vasculature in Uppsala Seniors and Uppsala Longitudinal Study of Adult Men. RESULTS: In a meta-analysis of the three cohorts, a genetically predicted 1 mmol/l increment of fasting glucose was associated with a 2% smaller total hip bone area (-0.67 cm2 [95% CI -1.30, -0.03; p = 0.039]), yet was also associated, albeit without reaching statistical significance, with a 4% higher total hip BMD (0.040 g/cm2 [95% CI -0.00, 0.07; p = 0.060]). CONCLUSIONS/INTERPRETATION: Fasting glucose may be a causal risk factor for smaller bone area at the hip, yet possibly for greater BMD. Further MR studies with larger sample sizes are required to corroborate these findings.
引用
- Mitchell A, Larsson SC, Fall T, et al. Fasting glucose, bone area and bone mineral density: a Mendelian randomisation study. Diabetologia. 2021. PMID: 33650017. doi:10.1007/s00125-021-05410-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。